The Human Microbiome Network

How interconnected microbial and neural systems shape the brain, heart, immunity, and whole-person health.

Your heart, brain, and gut are in constant conversation, and your resident microbes have joined it. This post maps the major human microbiomes and the routes connecting them to one another and to the organs they influence.

It keeps the spotlight on human evidence, borrowing from animal work only to sketch a plausible mechanism, never to promise a human cure (Cryan et al., 2019; Nguyen et al., 2021).

It treats the vagus nerve, the long cranial nerve linking the brainstem to the heart and gut, as one signaling wire in a larger network rather than a pipe that carries microbes to the brain (Fang & Zhang, 2024; Kaelberer et al., 2018). The goal throughout is practical: understand the network so you can treat it, not just the single organ in front of you (Ramadan et al., 2025).

One body, many microbial neighborhoods

Start with two words that people mix up. The microbiota are the microbes living at a given site, the actual residents (The Human Microbiome Project Consortium, 2012). The microbiome is broader, encompassing these microbes, their genes, their products, and the local conditions in which they live(The Human Microbiome Project Consortium, 2012). Bacteria hog the spotlight, but fungi form the mycobiome and viruses form the virome (The Integrative HMP Research Network Consortium, 2019). In humans, each body site handpicks its residents based on oxygen, acidity, moisture, nutrients, host secretions, and immune pressure (The Human Microbiome Project Consortium, 2012).

Now for a word you will hear constantly: dysbiosis. In humans, it simply means a disturbed microbial community, yet it does not specify a fixed pattern, nor does it prove causation (The Integrative HMP Research Network Consortium, 2019). Here is the catch. A disease can alter diet, transit time, oxygen, medications, and inflammation, and those changes can reshape the microbes in turn (Nguyen et al., 2021; The Integrative HMP Research Network Consortium, 2019). So before you blame the bugs, ask one question: did the microbial shift come before the disease, follow it, or help keep it going?

Some human samples demand extra caution. In a low-biomass microbiome, meaning a site with very few microbes such as lung tissue or blood, stray DNA from lab reagents can drown out the faint real signal (Salter et al., 2014). When researchers control for that contamination, they do not find a stable resident community in the human placenta during a healthy pregnancy (de Goffau et al., 2019). The safer read is that microbes may pass briefly through normally protected tissues during infection without ever settling in (de Goffau et al., 2019; Salter et al., 2014).

The gut: Your busiest metabolic and immune hub

The colon is the body's most crowded microbial city, while the stomach and small intestine keep smaller populations in check with acid, bile, oxygen, and constant flow (The Human Microbiome Project Consortium, 2012). Here the residents earn their keep. Gut microbes ferment the fibers we cannot digest and turn them into short-chain fatty acids (SCFAs), mainly acetate, propionate, and butyrate (Ramadan et al., 2025). Butyrate feeds the cells lining the colon, helps hold the gut barrier together, and cools inflammation (Chen et al., 2025; Li et al., 2025).

Those same metabolites help train the immune system, including regulatory T cells, which put the brakes on overactive responses (Furusawa et al., 2013). In humans, a fiber-rich diet supports these SCFA-producing bacteria and a calmer inflammatory tone (Li et al., 2025; Wastyk et al., 2021). The practical point is simple. Fiber supports a healthy ecosystem, but no single fiber pill can cure every microbiome-linked problem (Desai et al., 2016; Wastyk et al., 2021).

The gut is also a chemical factory. About 90% of the body's serotonin is made in the gut, not the brain, much of it by enterochromaffin cells, the hormone-releasing cells in the gut lining (Cryan et al., 2019; Ramadan et al., 2025). This gut serotonin does not flow straight into the brain, so picturing bacterial serotonin traveling up to lift mood is wrong (Hwang & Oh, 2025; Yano et al., 2015). Instead, it acts locally and signals upward through the enteric nervous system, the roughly 500 million neurons woven into the gut wall, and along the vagus nerve (Cryan et al., 2019).

Antibiotics leave a mark. Broad-spectrum courses can thin gut diversity in people and keep some species altered for months, though recovery varies (Palleja et al., 2018). Many everyday non-antibiotic drugs also slow human gut bacteria in the laboratory, which is why a medication history matters when you read a result (Maier et al., 2018). You can protect resilience with a few habits: reserve antimicrobials for clear reasons, note recent exposures, and skip the promise that one supplement will “reset” the gut.

The mouth: Gateway, reservoir, and partner to your blood vessels

The mouth is not one habitat but several, spread across the tongue, saliva, cheeks, teeth, and the crevice around each gum (The Human Microbiome Project Consortium, 2012). Dental plaque is a classic biofilm, a structured community where microbes stick to a surface and live inside a self-made matrix (Griffen et al., 2012). In periodontitis, the trouble comes less from a single villain and more from the whole community of bacteria growing and inflaming the gum (Abusleme et al., 2013; Griffen et al., 2012).

We swallow mouth microbes all day long, yet a healthy gut usually refuses them lasting residence (Atarashi et al., 2017). The exception is telling. In inflamed guts, oral pathobionts, normally harmless residents that can turn troublemaker in the wrong setting, can move in and stoke inflammation (Atarashi et al., 2017). This oral-to-gut route seems to matter most when inflammation or disruption opens a door (Atarashi et al., 2017).

The mouth even helps manage blood pressure. Nitrate-reducing bacteria on the tongue convert nitrate from saliva into nitrite, which the body turns into nitric oxide, a molecule that relaxes blood vessels (Kapil et al., 2013). When researchers wiped out these bacteria with antiseptic mouthwash, nitrate conversion fell and blood pressure rose (Kapil et al., 2013). Even so, that finding is no reason to change a patient's prescribed oral care without a clinical reason (Kapil et al., 2013).

The clinical message is bigger than a bright smile. Intensive gum treatment improved blood vessel function in patients once the initial inflammation from the treatment had settled (Tonetti et al., 2007). Treat bleeding gums and periodontitis as the inflammatory diseases they are, not as cosmetic nuisances. Ask about dental symptoms in the medical history, and refer to dental care when gum disease complicates diabetes or heart risk.

The airways: A thin community with outsized immune stakes

The airway deviates from the usual pattern, since the upper airway harbors denser communities than the lung below (Charlson et al., 2011). In healthy adults, the lung's microbes reflect a running balance between what arrives, what gets cleared, and what manages to grow (Charlson et al., 2011). Most of those arrivals occur via microaspiration, the tiny, everyday trickle of oral secretions that slips into the airway (Charlson et al., 2011).

When lower-airway samples are colonized by oral microbes, they tend to carry a Th17-Cell inflammatory signature, a T-cell pattern tied to mucosal defense and disease, in humans (Segal et al., 2016). Animal studies suggest the gut can shape lung immunity from a distance, but that mechanism is not yet a human treatment (Ichinohe et al., 2011; Trompette et al., 2014). So the human signal is clearest for the mouth-to-lung link, not for a probiotic against asthma (Segal et al., 2016).

The practical airway actions are unglamorous. Guard oral health, because enrichment of the lower airway with oral bacteria tracks with lung inflammation in people (Segal et al., 2016). Lower aspiration risk when it applies, and choose antibiotics with an eye on both the target and the collateral damage (Charlson et al., 2011).

The skin: A living barrier wired to your nerves

Skin is a patchwork of oily, damp, and dry terrain, and each of us carries a partly stable microbial fingerprint across it (Grice et al., 2009; Oh et al., 2016). Resident microbes earn their place by crowding out pathogens and tuning the local immune response (Nakatsuji et al., 2017). Often, the meaningful unit is the strain, since two members of the same species can affect the skin differently (Nakatsuji et al., 2017).

Consider a small turf war on the skin. Some friendly staphylococci produce antimicrobial compounds that suppress Staphylococcus aureus, and these protective strains were in short supply in patients with eczema (Nakatsuji et al., 2017). Animal work hints at a direct skin-to-nerve pathway, in which bacteria communicate with sensory neurons, but the human version of that story remains thin (Chiu et al., 2013). For now, the clearest human signal sits at the level of the barrier and local immunity (Nakatsuji et al., 2017).

“Good skin care protects the barrier while it treats the disease. Scrubbing with harsh antiseptics repeatedly can strip away protective microbes along with pathogens, and unchecked inflammation also reshapes the habitat(Nakatsuji et al., 2017). So read any skin microbiome result alongside the practical context: the site sampled, moisture, topical products, occupation, and recent antibiotics (Grice et al., 2009; Oh et al., 2016).”

The urogenital tract: protection that answers to hormones

The vaginal microbiome plays by different rules. In many reproductive-age women, Lactobacillus species dominate, producing lactic acid and maintaining a low pH(Ravel et al., 2011). Researchers sort these recurring patterns into a community state type, a way to label vaginal community composition, though the states shift from person to person and over time (Gajer et al., 2012; Ravel et al., 2011). Here is the twist: unlike the gut, a low-diversity vaginal community can signal strong defense rather than weakness (Ravel et al., 2011).

When Lactobacillus loses its grip, the local environment can turn more inflammatory, though the pattern is not identical in everyone (Anahtar et al., 2015). Long-term multi-omic studies have tied vaginal microbial states and host responses to the risk of preterm birth (The Integrative HMP Research Network Consortium, 2019). The lesson is to diagnose and treat symptomatic bacterial vaginosis with care, rather than forcing every patient into one idealized profile (Anahtar et al., 2015; Ravel et al., 2011).

The bladder is not the sterile chamber textbooks once described (Wolfe et al., 2012). Using culture-independent and enhanced-culture methods, researchers found resident bacterial communities in many women, a community now called the urobiome (Wolfe et al., 2012). The female urobiome even shares strains with neighboring vaginal communities, which points to one connected lower urogenital ecosystem (Thomas-White et al., 2018).

These lower organs mostly talk to the brain through pelvic and spinal nerves, not the vagus (Hall & Hall, 2021). Their effects on distant organs travel more often by hormones, immune messengers, pregnancy physiology, and infection (Hall & Hall, 2021; The Integrative HMP Research Network Consortium, 2019). Sampling technique matters, because voided urine can blur signals from the bladder, urethra, and vulvovaginal area (Price et al., 2020; Wolfe et al., 2012).

How our neighborhoods talk: Nerves, immunity, hormones, and chemistry

So how do these separate neighborhoods actually stay in touch? Microbiomes use five broad channels (The Integrative HMP Research Network Consortium, 2019). They release metabolites, adjust immune messengers, sway hormone-producing cells, tap into peripheral nerves, and physically move between connected surfaces (O'Mahony et al., 2025; The Integrative HMP Research Network Consortium, 2019). These channels usually work in concert, so the tidy word “axis” can hide how tangled the real network is (Cryan et al., 2019).

At the center of this cross-talk sits a brain hub called the central autonomic network (CAN), the linked brain regions that read the body and adjust its autonomic output (Benarroch, 1993; Lamotte et al., 2021). The vagus nerve is its main cable, and about 80% of vagal fibers run from the body to the brain, not the other way (Fang & Zhang, 2024). Those fibers carry heart and gut data to the same brainstem relay, so the microbiome's signals and the heartbeat's signals arrive at one shared desk (Benarroch, 1993; O'Mahony et al., 2025).

The gut also talks through fast electrical wiring. Specialized enteroendocrine cells sense a meal and fire off hormones and nerve signals within seconds, helping set appetite, insulin release, and satiety (Kaelberer et al., 2018). Animal experiments show these cells can form near-synaptic contacts with vagal neurons, which makes the wiring plausible, but they do not prove a probiotic treats human anxiety (Bravo et al., 2011; Kaelberer et al., 2018). The honest summary is that the circuit exists, while its clinical control in people is still being worked out (Cryan et al., 2019).

Stress runs on its own circuit, the hypothalamic-pituitary-adrenal (HPA) axis, the hormone system that coordinates the body's response to pressure (Lamotte et al., 2021; Sudo et al., 2004). Chronic activation shows up in people as high cortisol, disturbed sleep, and a more permeable gut (McEwen, 2003; Thayer et al., 2006). Stress and the gut push on each other, and animal work traces one route from the amygdala through the vagus to mucus-secreting glands in the small intestine (Chang et al., 2024). The clinical point stands for humans: psychological strain can reshape the gut and its immune tone (Hwang & Oh, 2025).

Immunity offers a slower but wider channel (O'Mahony et al., 2025). A broken barrier can allow microbial translocation, the passage of microbes or their products across the lining, which raises the body's exposure to inflammatory signals, and the vagus can dampen that same inflammation through a neural reflex (Borovikova et al., 2000; Brenchley et al., 2006). Metabolites add yet another route, as the bloodstream carries SCFAs, bile-acid products, and other small molecules to far-off tissues (Aronov et al., 2011; Sayin et al., 2013).

The heart, brain, and gut as one network: Stability through change

Zoom out and a bigger principle appears. Your body does not defend fixed setpoints like a thermostat; it predicts what it will need and adjusts in advance, a process called allostasis, meaning stability through change (McEwen, 2000; Sterling & Eyer, 1988). The brain runs this through the central autonomic network, reading the vagus nerve, the HPA axis, circulating immune signals, and metabolic hormones (Lamotte et al., 2021; Thayer et al., 2006). Short term, this is brilliant. Cortisol frees up energy, the heart pumps harder, and immune cells hunt pathogens (McEwen, 2003).

The trouble starts when these systems never switch off. The cumulative wear is allostatic load, and in people it shows up as visceral fat, insulin resistance, chronic inflammation, low heart rate variability, and a leakier gut (McEwen, 2003; McEwen & Stellar, 1993). The damage does not stay in one organ, because the heart-brain and gut-brain axes share the same nerve, immune messengers, and stress hormones (Thayer et al., 2006). When vagal tone falls, people can show lower heart rate variability, higher glucose, higher cortisol, and more inflammation at once (Thayer et al., 2006). That reframes comorbidity, since depression, heart disease, and gut disorders often travel together as one network under strain (Fang & Zhang, 2024; McEwen, 2003).

This is why heart rate variability (HRV), the beat-to-beat variation in your pulse, tells you about the brain and not only the heart (Thayer & Lane, 2000). In the neurovisceral integration model, the prefrontal cortex calms threat circuits like the amygdala and sends that calm to the heart along the vagus (Thayer & Lane, 2009). Strong prefrontal control produces flexible regulation and high HRV, while chronic stress, anxiety, and depression weaken it and drop HRV (Thayer et al., 2012). Human neuroimaging confirms that HRV tracks activity in the amygdala and prefrontal cortex, making it a practical window into the whole system (Thayer et al., 2012).

The gut sits inside this triangle through its chemistry. Gut bacteria turn choline and L-carnitine from red meat, eggs, and liver into a compound the liver converts to trimethylamine N-oxide (TMAO), and higher TMAO independently predicts heart attack and stroke in people (Chen et al., 2025; Li et al., 2025; Tang et al., 2013; Wang et al., 2011).

Pulling the other way, butyrate-producing bacteria protect the vessels and brain, yet heart failure patients consistently show depleted butyrate-producing bacteria, a leakier gut, and higher circulating endotoxin levels(Li et al., 2025). So the same gut can amplify a harmful signal while losing its protective one (Chen et al., 2025). Diet shapes microbes, microbes shape metabolites, and metabolites shape the heart and brain (Li et al., 2025).

The brain also has to listen to all this. Interoception, the sense of the body's internal state, such as heartbeat, breathing, and gut tension, is how the body checks whether its predictions are working (Fang & Zhang, 2024). Each heartbeat sends a signal up the vagus that the cortex registers as a measurable heartbeat-evoked potential (HEP) (Kumagai et al., 2025). People with sharper interoceptive awareness regulate emotions better, while blunted interoception tracks with anxiety and depression (Kumagai et al., 2025; Murphy et al., 2019). This matters clinically because heartbeat awareness and mindfulness practices can strengthen these circuits and lower allostatic load (Dohata et al., 2025; Kumagai et al., 2025).

The gut and the mind: mood, depression, and serious mental illness

Nowhere is the gut-brain link more clinically loaded than in mood. When dysbiosis shifts tryptophan away from serotonin, and down the kynurenine pathway, central serotonin can fall while a neurotoxic metabolite, quinolinic acid, rises, a pattern seen in human major depression (O'Mahony et al., 2025; Ramadan et al., 2025). This helps explain why gut symptoms and depression so often arrive together (Hwang & Oh, 2025). It also warns against a simple story, since the same inflammation that reshapes the gut can independently drag down mood (O'Mahony et al., 2025).

A systematic review of the serious mental illness (SMI) literature, covering schizophrenia, bipolar disorder, and major depressive disorder, found consistent human signals in the gut (Nguyen et al., 2021). Schizophrenia samples showed reduced microbial diversity and more pro-inflammatory bacteria, while depression showed fewer SCFA-producing Lactobacillus and Bifidobacterium (Nguyen et al., 2021). Bipolar disorder had thinner evidence, with hints of fewer anti-inflammatory Faecalibacterium (Nguyen et al., 2021). These shifts point toward the shared inflammation seen across these disorders, without proving the microbes cause them (Nguyen et al., 2021).

Two cautions keep this honest. First, psychotropic medicines themselves change the gut community, so an altered microbiome in a treated patient may reflect the drug as much as the disease (Nguyen et al., 2021). Second, human trials of probiotics, dietary change, and fecal microbiota transplantation (FMT), the transfer of stool microbes from a screened donor, remain small and inconsistent (Nguyen et al., 2021). The field needs large, long-term studies before anyone promises a microbiome cure for mental illness (Nguyen et al., 2021).

The mind-gut story feeds straight back into the heart. In humans, depression roughly doubles the odds of developing cardiovascular disease, driving sympathetic overdrive, low HRV, inflammation, and a degraded microbiome all at once (Fang & Zhang, 2024; O'Mahony et al., 2025). The reverse runs just as hard, since heart failure cuts blood flow to brain and gut (Fang & Zhang, 2024). Strokes that damage the insular cortex, a deep brain region that maps the body's internal state, can trigger dangerous arrhythmias known as stroke-heart syndrome (Lohman et al., 2026; Scheitz et al., 2022). The mandate is integrated screening, and cardiology guidelines already advise screening cardiac patients for depression (Fang & Zhang, 2024).

Ripple effects on the liver, kidney, and metabolism

Follow the metabolites downstream, and the liver and kidney come into view. The liver sits just below the gut and processes much of what arrives via portal blood, includingbile acids that gut microbes reshape (Hall & Hall, 2021; Sayin et al., 2013). The kidney then clears many of these microbial co-products, and studies in human dialysis patients show the colon supplies a large share of several retained uremic solutes (Aronov et al., 2011). When kidneys fail, the gut's chemistry becomes part of the clinical problem (Aronov et al., 2011).

The gut even reaches blood pressure. Oral nitrate metabolism supports nitric oxide and can shift vascular tone in humans (Kapil et al., 2013). Animal work adds SCFA-sensing receptors that alter renin release, though that specific mechanism is not yet confirmed in people (Pluznick et al., 2013). The vagus clearly steers the heart's autonomic rhythm, but the microbiome's clinical heart effects run mostly through metabolites and inflammation (Hall & Hall, 2021).

Metabolism feels the network too. The microbial metabolome, the full set of small molecules a community produces or modifies, overlaps with the body's handling of blood sugar (Pedersen et al., 2016). Human multi-omic studies connect gut microbial functions and circulating metabolites to insulin sensitivity (Pedersen et al., 2016). Associations between microbial features and mood or metabolism are real, but a link alone cannot prove direction or a treatment effect (Valles-Colomer et al., 2019). That argues for looking at the whole person, not for diagnosing from a stool test alone (Nguyen et al., 2021; Pedersen et al., 2016).

Clinical implications: Protect function, treat disease, and resist hype

A useful microbiome history costs nothing and explains a lot. Start with diet, bowel habits, oral disease, smoking, alcohol, recent infection, antibiotic exposure, and current medications, then add pregnancy, urinary symptoms, skin treatments, and major life stress (Gajer et al., 2012; Palleja et al., 2018). Because the heart, brain, and gut share one regulatory system, add depression screening, gut symptoms, and simple inflammatory markers to gauge allostatic load (Fang & Zhang, 2024). This story often tells you more than a single snapshot specimen, because microbial communities keep shifting and depend on the site (Price et al., 2020).

Food remains the most reliable lever. In a randomized human trial, a diet rich in fermented foods raised gut microbial diversity and lowered several inflammatory proteins, while a high-fiber diet boosted the microbes' carbohydrate-processing capacity with wide differences between people (Wastyk et al., 2021). Fiber feeds butyrate producers, while red meat and processed food push TMAO up, so a Mediterranean pattern tends to help all three axes at once (Chen et al., 2025; Li et al., 2025). Fit any dietary advice to allergies, immune status, metabolic needs, and gut tolerance (Wastyk et al., 2021).

Probiotics deserve measured hope. Their effects depend on the strain, the condition, and the person, and human studies show patchy colonization and slower recovery after some off-the-shelf regimens (Suez et al., 2018; Zmora et al., 2018). A narrower group called psychobiotics, specific Lactobacillus and Bifidobacterium strains, has reduced anxiety and depression in human trials, likely by way of vagal signaling and tryptophan availability (O'Mahony et al., 2025; Ramadan et al., 2025). Match a product to real evidence rather than treating “probiotic” as a single drug class (Nguyen et al., 2021).

One microbiome therapy has earned a clear, regulated role: recurrent Clostridioides difficile infection (U.S. Food and Drug Administration, 2022, 2023). The FDA approved REBYOTA and VOWST to prevent recurrence in adults after antibacterial treatment for recurrent infection (U.S. Food and Drug Administration, 2022, 2023). These are not general wellness products, and they are not meant to treat an active infection or a psychiatric disorder (Nguyen et al., 2021; U.S. Food and Drug Administration, 2023).

Some of the most promising drugs act on the whole network. GLP-1 receptor agonists, first built for diabetes, carry receptors in the pancreas, brain, blood vessels, and gut (Adamou et al., 2024; Jia & Li, 2025). A meta-analysis of cardiovascular trials with more than 82,000 people found a 15% to 16% drop in stroke risk versus placebo, and 2024 stroke-prevention guidelines now recommend them for high-risk patients with diabetes (Adamou et al., 2024; Bushnell et al., 2024). They point to the future of pharmacology: multi-axis rather than single-organ (Jia & Li, 2025; Maskery et al., 2022).

Neuromodulation offers another network-level tool. Vagus nerve stimulation, which delivers electrical pulses to the vagus, is FDA-approved for treatment-resistant depression and stroke rehabilitation, and a 12-month sham-controlled trial of 493 patients improved depression response and remission (Aaronson et al., 2024; Bu et al., 2026). Because the vagus innervates both the heart and the gut, stimulating it acts on multiple axes simultaneously (Beltran-Navarro et al., 2024; Bu et al., 2026).

Noninvasive ear-clip versions are now in active study (Beltran-Navarro et al., 2024).

You can also shift the system without a prescription. Slow breathing at about six breaths per minute, the resonance frequency where the baroreflex works best, raises HRV and lowers cortisol, and because the vagus serves both heart and gut, it improves cardiac regulation and gut motility together (Mitsea et al., 2024). Music with a steady tempo can slow heart and breathing rates through the same autonomic channels, even in patients with reduced consciousness (Mitsea et al., 2024). Combine slow breathing, dietary fiber, and body-awareness training for a low-cost intervention that touches all three axes (Kumagai et al., 2025; Mitsea et al., 2024).

Finally, be honest about measurement. Consumer wearables now track HRV in real time, and through the neurovisceral integration lens, that number indexes how well the central autonomic network is coping (Cammisuli et al., 2025; Park et al., 2019). Newer hemodynamic measures such as arterial elastance may sharpen cardiovascular risk assessment beyond blood pressure alone (Antohi et al., 2022). Emerging microbiome tests, by contrast, still describe who is present without proving what they do or which treatment to pick, so pair any result with repeat sampling, good controls, and the clinical picture (Nguyen et al., 2021; Salter et al., 2014).

Bringing it together: Treat the network, respect microbiome differences

Step back and the pattern comes into focus. The body hosts a connected set of microbial ecosystems, not one all-purpose microbiome, and those ecosystems plug into a single regulatory network that also runs the heart and brain (Ramadan et al., 2025; The Integrative HMP Research Network Consortium, 2019). The gut carries the strongest human evidence for effects on metabolism, immunity, mood, and the heart, while the mouth, airway, skin, and urogenital communities add their own barriers and signals (Nguyen et al., 2021; The Integrative HMP Research Network Consortium, 2019).

The vagus nerve, the central autonomic network, and shared stress hormones tie it all together, which is why chronic strain lands on several systems at once (Fang & Zhang, 2024; McEwen, 2003; Thayer et al., 2006). Treat the network, respect each site's differences, and let human evidence set the pace (Nguyen et al., 2021).

Five key takeaways

1. Each site sets its own definition of health. Gut diversity is not a universal yardstick for the vagina, airway, skin, or bladder.

2. The gut reaches distant organs through metabolites, immune signals, hormones, the circulation, and the vagus nerve, and in people TMAO raises cardiovascular risk while butyrate lowers it.

3. The heart, brain, and gut form one network coordinated by the central autonomic network, so depression, heart disease, and gut disorders often rise and fall together as allostatic load.

4. Human gut signals are real in serious mental illness and depression, but medications, diet, and study limits mean no stool test yet diagnoses a psychiatric disorder.

5. Favor proven, network-level tools, from fiber, fermented foods, slow breathing, and HRV training to GLP-1 agonists and regulated FMT products, over promises to “balance” or “reset” your microbiome.

Glossary

allostasis: the process of maintaining stability through continuous adaptive change rather than fixed setpoints.

allostatic load: the cumulative physiological wear from chronically activated or poorly regulated stress systems.

biofilm: a structured microbial community attached to a surface and embedded in a self-produced matrix.

central autonomic network (CAN): the interconnected brain regions that read visceral signals and coordinate autonomic, hormonal, and behavioral output.

community state type: a recurring pattern used to classify vaginal microbial community composition.

dysbiosis: a context-dependent disturbance in microbial composition or function that may accompany, follow, or help sustain disease.

enteric nervous system: the roughly 500 million neurons in the gut wall that regulate motility, secretion, and blood flow and communicate with the brain.

enterochromaffin cells: intestinal epithelial cells that produce most peripheral serotonin and respond to microbial metabolites.

enteroendocrine cells: specialized gut epithelial cells that sense luminal contents and release hormones or neural signals.

fecal microbiota transplantation (FMT): transfer of stool microbes from a screened donor to a recipient to restore microbial balance.

GLP-1 receptor agonists: a drug class that mimics the incretin hormone GLP-1 and acts on receptors in the pancreas, brain, blood vessels, and gut.

heart rate variability (HRV): the beat-to-beat variation in heart rate, used as a peripheral index of central autonomic network function.

heartbeat-evoked potential (HEP): a brain signal reflecting cortical processing of each heartbeat, modulated by attention and interoceptive awareness.

HPA axis: the hypothalamic-pituitary-adrenal endocrine system that coordinates physiological responses to stress.

insular cortex: a brain region central to sensing the body's internal state and regulating autonomic function.

interoception: the sense of the body's internal state, including heartbeat, breathing, hunger, and gut tension.

intestinal barrier: the mucus, epithelial, immune, and vascular interface that controls exchange between the gut lumen and internal tissues.

kynurenine pathway: the main route of tryptophan breakdown, driven up by inflammation, that can divert tryptophan away from serotonin.

low-biomass microbiome: a microbial community with little biological material, making contamination and sampling error especially consequential.

metabolome: the complete set of small molecules present in a biological system at a given time.

microaspiration: small-volume movement of oral or gastric material into the lower respiratory tract.

microbial translocation: passage of microorganisms or their products across an epithelial barrier into tissue or circulation.

microbiome: the microorganisms, genes, products, and ecological conditions associated with a defined habitat.

microbiota: the microorganisms present in a defined habitat.

mycobiome: the fungal component of a microbiome.

nitrate-reducing bacteria: oral bacteria that convert nitrate to nitrite within the enterosalivary nitric oxide pathway.

pathobiont: a normally tolerated resident organism that can promote disease when host or ecological conditions change.

psychobiotics: probiotic strains with evidence for beneficial effects on brain function through gut-brain pathways.

quinolinic acid: a neurotoxic kynurenine-pathway metabolite that rises with inflammation and is elevated in major depression.

regulatory T cells: T lymphocytes that suppress excessive immune activation and support immune tolerance.

resonance frequency: the breathing rate, near six breaths per minute, at which heart rate variability and baroreflex gain peak.

serious mental illness (SMI): a group of disabling psychiatric conditions including schizophrenia, bipolar disorder, and major depressive disorder.

short-chain fatty acids (SCFAs): microbial fermentation products, especially acetate, propionate, and butyrate, that act as fuels and signaling molecules.

stroke-heart syndrome: cardiac injury and arrhythmias after a stroke, driven by disrupted central autonomic control.

Th17 cells: CD4-positive T cells that produce interleukin-17 and participate in mucosal defense and inflammatory disease (Segal et al., 2016).

TMAO: trimethylamine N-oxide, a host-microbe co-metabolite formed after microbial production of trimethylamine and hepatic oxidation.

urobiome: the microbial community of the urinary tract, including resident bladder organisms identified by sequencing and enhanced culture.

vagus nerve: a cranial nerve with sensory and motor pathways connecting the brainstem with thoracic and abdominal organs.

vagus nerve stimulation: delivery of electrical pulses to the vagus nerve, used for treatment-resistant depression and stroke rehabilitation.

virome: the viral component of a microbiome, including bacteriophages and eukaryotic viruses.

References

Aaronson, S. T., Sackeim, H. A., Conway, C. R., Bunker, M. T., Vetter, M., Biren, B., Carlin, A., Rush, A. J., & George, M. S. (2024). Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trial. Brain Stimulation, 17(6), 1344-1356. https://doi.org/10.1016/j.brs.2024.12.1216

Abusleme, L., Dupuy, A. K., Dutzan, N., Silva, N., Burleson, J. A., Strausbaugh, L. D., Gamonal, J., & Diaz, P. I. (2013). The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. The ISME Journal, 7(5), 1016-1025. https://doi.org/10.1038/ismej.2012.174

Adamou, A., Barkas, F., Milionis, H., & Ntaios, G. (2024). Glucagon-like peptide-1 receptor agonists and stroke: A systematic review and meta-analysis of cardiovascular outcome trials. European Stroke Journal, 9(3), 530-539. https://doi.org/10.1177/23969873241234238

Anahtar, M. N., Byrne, E. H., Doherty, K. E., Bowman, B. A., Yamamoto, H. S., Soumillon, M., Padavattan, N., Ismail, N., Moodley, A., Sabatini, M. E., Ghebremichael, M. S., Nusbaum, C., Huttenhower, C., Virgin, H. W., & Kwon, D. S. (2015). Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity, 42(5), 965-976. https://doi.org/10.1016/j.immuni.2015.04.019

Antohi, E.-L., Chioncel, O., & Mihaileanu, S. (2022). Overcoming the limits of ejection fraction and ventricular-arterial coupling in heart failure. Frontiers in Cardiovascular Medicine, 8, 750965. https://doi.org/10.3389/fcvm.2021.750965

Aronov, P. A., Luo, F. J.-G., Plummer, N. S., Quan, Z., Holmes, S., Hostetter, T. H., & Meyer, T. W. (2011). Colonic contribution to uremic solutes. Journal of the American Society of Nephrology, 22(9), 1769-1776. https://doi.org/10.1681/ASN.2010121220

Atarashi, K., Suda, W., Luo, C., Kawaguchi, T., Motoo, I., Narushima, S., Kiguchi, Y., Yasuma, K., Watanabe, E., Tanoue, T., Thaiss, C. A., Sato, H., Toyooka, K., Said, H. S., Yamagami, H., Rice, S. A., Gevers, D., Johnson, R. C., Segre, J. A., . . . Honda, K. (2017). Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science, 358(6361), 359-365. https://doi.org/10.1126/science.aan4526

Beltran-Navarro, E., Langdon, A., Mamo, E., O'Connor, S. R., Quinn, T. J., & Broomfield, N. M. (2024). Clinical application of transcutaneous auricular vagus nerve stimulation: A scoping review. Disability and Rehabilitation, 46(24), 5730-5760. https://doi.org/10.1080/09638288.2024.2313123

Benarroch, E. E. (1993). The central autonomic network: Functional organization, dysfunction, and perspective. Mayo Clinic Proceedings, 68(10), 988-1001. https://doi.org/10.1016/s0025-6196(12)62272-1

Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405(6785), 458-462. https://doi.org/10.1038/35013070

Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011). Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences, 108(38), 16050-16055. https://doi.org/10.1073/pnas.1102999108

Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L., Landay, A., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., & Douek, D. C. (2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine, 12(12), 1365-1371. https://doi.org/10.1038/nm1511

Bu, Y., Toffa, D. H., Bhatt, D. K., & Bhatt, N. R. (2026). A review of vagus nerve stimulation for disease: Comprehensive theory and evidence for mechanisms of action. Comprehensive Physiology, 16(1), e70109. https://doi.org/10.1002/cph4.70109

Bushnell, C. D., Chaturvedi, S., Gage, K. R., Herson, P. S., Hreib, K., Kernan, W. N., Leira, E. C., Meschia, J. F., Rundek, T., Seshadri, S., & Waddy, S. P. (2024). 2024 AHA/ASA guideline for the primary prevention of stroke. Stroke, 55(12), e344-e413. https://doi.org/10.1161/STR.0000000000000475

Cammisuli, D. M., Lautarescu, A., Manni, L., Castelnuovo, G., Marchetti, D., Fontana, A., & Cau, R. (2025). The heart-brain axis in the artificial intelligence era. International Journal of Molecular Sciences, 26(17), 8217. https://doi.org/10.3390/ijms26178217

Chang, H., Perkins, M. H., Novaes, L. S., Qian, F., Zhang, T., Neckel, P. H., Scherer, S., Ley, R. E., Han, W., & de Araujo, I. E. (2024). Stress-sensitive neural circuits change the gut microbiome via duodenal glands. Cell, 187(19), 5393-5412.e30. https://doi.org/10.1016/j.cell.2024.07.019

Charlson, E. S., Bittinger, K., Haas, A. R., Fitzgerald, A. S., Frank, I., Yadav, A., Bushman, F. D., & Collman, R. G. (2011). Topographical continuity of bacterial populations in the healthy human respiratory tract. American Journal of Respiratory and Critical Care Medicine, 184(8), 957-963. https://doi.org/10.1164/rccm.201104-0655OC

Chen, Z., Zhang, Y., Li, M., & Wang, X. (2025). The gut-heart axis: Unveiling the roles of gut microbiota in cardiovascular diseases. Frontiers in Cardiovascular Medicine, 12, 1572948. https://doi.org/10.3389/fcvm.2025.1572948

Chiu, I. M., Heesters, B. A., Ghasemlou, N., Von Hehn, C. A., Zhao, F., Tran, J., Wainger, B., Strominger, A., Muralidharan, S., Horswill, A. R., Wardenburg, J. B., Hwang, S. W., Carroll, M. C., & Woolf, C. J. (2013). Bacteria activate sensory neurons that modulate pain and inflammation. Nature, 501(7465), 52-57. https://doi.org/10.1038/nature12479

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., Guzzetta, K. E., Jaggar, M., Long-Smith, C. M., Lyte, J. M., Martin, J. A., Molinero-Perez, A., Moloney, G., Morelli, E., Morillas, E., . . . Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. https://doi.org/10.1152/physrev.00018.2018

de Goffau, M. C., Lager, S., Sovio, U., Gaccioli, F., Cook, E., Peacock, S. J., Parkhill, J., Charnock-Jones, D. S., & Smith, G. C. S. (2019). Human placenta has no microbiome but can contain potential pathogens. Nature, 572(7769), 329-334. https://doi.org/10.1038/s41586-019-1451-5

Desai, M. S., Seekatz, A. M., Koropatkin, N. M., Kamada, N., Hickey, C. A., Wolter, M., Pudlo, N. A., Kitamoto, S., Terrapon, N., Muller, A., Young, V. B., Henrissat, B., Wilmes, P., Stappenbeck, T. S., Núñez, G., & Martens, E. C. (2016). A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell, 167(5), 1339-1353.e21. https://doi.org/10.1016/j.cell.2016.10.043

Dohata, M., Kaneko, N., Takahashi, R., Suzuki, Y., & Nakazawa, K. (2025). Posture-dependent modulation of interoceptive processing: A heartbeat-evoked potential study. European Journal of Neuroscience, 61(1), e70021. https://doi.org/10.1111/ejn.70021

Fang, S., & Zhang, W. (2024). Heart-brain axis: A narrative review of the interaction between depression and arrhythmia. Biomedicines, 12(8), 1719. https://doi.org/10.3390/biomedicines12081719

Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., Takahashi, M., Fukuda, N. N., Murakami, S., Miyauchi, E., Hino, S., Atarashi, K., Onawa, S., Fujimura, Y., Lockett, T., . . . Ohno, H. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504(7480), 446-450. https://doi.org/10.1038/nature12721

Gajer, P., Brotman, R. M., Bai, G., Sakamoto, J., Schütte, U. M. E., Zhong, X., Koenig, S. S. K., Fu, L., Ma, Z. S., Zhou, X., Abdo, Z., Forney, L. J., & Ravel, J. (2012). Temporal dynamics of the human vaginal microbiota. Science Translational Medicine, 4(132), 132ra52. https://doi.org/10.1126/scitranslmed.3003605

Grice, E. A., Kong, H. H., Conlan, S., Deming, C. B., Davis, J., Young, A. C., Bouffard, G. G., Blakesley, R. W., Murray, P. R., Green, E. D., Turner, M. L., & Segre, J. A. (2009). Topographical and temporal diversity of the human skin microbiome. Science, 324(5931), 1190-1192. https://doi.org/10.1126/science.1171700

Griffen, A. L., Beall, C. J., Campbell, J. H., Firestone, N. D., Kumar, P. S., Yang, Z. K., Podar, M., & Leys, E. J. (2012). Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. The ISME Journal, 6(6), 1176-1185. https://doi.org/10.1038/ismej.2011.191

Hall, J. E., & Hall, M. E. (2021). Guyton and Hall textbook of medical physiology (14th ed.). Elsevier.

Hwang, Y. K., & Oh, J. S. (2025). Interaction of the vagus nerve and serotonin in the gut-brain axis. International Journal of Molecular Sciences, 26(3), 1160. https://doi.org/10.3390/ijms26031160

Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S., & Iwasaki, A. (2011). Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proceedings of the National Academy of Sciences, 108(13), 5354-5359. https://doi.org/10.1073/pnas.1019378108

Jia, Q., & Li, Z. (2025). Glucagon-like peptide-1 receptor agonists in the prevention of ischemic stroke. Journal of Stroke, 27(3), 289-301. https://doi.org/10.5853/jos.2025.00584

Kaelberer, M. M., Buchanan, K. L., Klein, M. E., Barth, B. B., Montoya, M. M., Shen, X., & Bohórquez, D. V. (2018). A gut-brain neural circuit for nutrient sensory transduction. Science, 361(6408), eaat5236. https://doi.org/10.1126/science.aat5236

Kapil, V., Haydar, S. M. A., Pearl, V., Lundberg, J. O., Weitzberg, E., & Ahluwalia, A. (2013). Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radical Biology and Medicine, 55, 93-100. https://doi.org/10.1016/j.freeradbiomed.2012.11.013

Kumagai, R., Onoda, K., Nishimura, T., & Yamaguchi, S. (2025). Heartbeat evoked potentials reflect interoceptive awareness during an emotional situation. Scientific Reports, 15, 8134. https://doi.org/10.1038/s41598-025-92854-4

Lamotte, G., Shouman, K., & Benarroch, E. E. (2021). Stress and central autonomic network. Autonomic Neuroscience: Basic and Clinical, 235, 102870. https://doi.org/10.1016/j.autneu.2021.102870

Li, X., Wang, J., Zhang, H., & Liu, Y. (2025). Gut-heart axis: The role of gut microbiota and metabolites in heart failure. Circulation Research, 137(4), 456-472. https://doi.org/10.1161/circresaha.125.325516

Lohman, T. K., Breit, S., Grefkes, C., & Fink, G. R. (2026). Central autonomic network dysfunction in stroke-heart syndrome. Frontiers in Neuroscience, 20, 1690302. https://doi.org/10.3389/fnins.2026.1690302

Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E. E., Brochado, A. R., Fernandez, K. C., Dose, H., Mori, H., Patil, K. R., Bork, P., & Typas, A. (2018). Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 555(7698), 623-628. https://doi.org/10.1038/nature25979

Maskery, M. P., Holscher, C., Jones, S. P., Price, C. I., Strain, W. D., Watkins, C. L., Werring, D. J., & Emsley, H. C. A. (2022). Protection against stroke with glucagon-like peptide-1 receptor agonists: A comprehensive review. Cardiovascular Diabetology, 21, 242. https://doi.org/10.1186/s12933-022-01686-3

McEwen, B. S. (2000). Allostasis, allostatic load, and the aging nervous system. Neurochemical Research, 25(9-10), 1219-1231. https://doi.org/10.1023/A:1007687911139

McEwen, B. S. (2003). Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology, 22(2), 108-124. https://doi.org/10.1016/S0893-133X(99)00129-3

McEwen, B. S., & Stellar, E. (1993). Stress and the individual: Mechanisms leading to disease. Archives of Internal Medicine, 153(18), 2093-2101. https://doi.org/10.1001/archinte.1993.00410180039004

Mitsea, E., Drigas, A., & Skianis, C. (2024). Breathing interventions for mental and emotional health: A systematic review. Electronics, 13(12), 2253. https://doi.org/10.3390/electronics13122253

Murphy, J., Brewer, R., Catmur, C., & Bird, G. (2019). Interoception and psychopathology: A developmental neuroscience perspective. Developmental Cognitive Neuroscience, 23, 45-56. https://doi.org/10.1016/j.dcn.2016.12.006

Nakatsuji, T., Chen, T. H., Narala, S., Chun, K. A., Two, A. M., Yun, T., Shafiq, F., Kotol, P. F., Bouslimani, A., Melnik, A. V., Latif, H., Kim, J. N., Lockhart, A., Artis, K., David, G., Taylor, P., Streib, J., Dorrestein, P. C., Grier, A., . . . Gallo, R. L. (2017). Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Science Translational Medicine, 9(378), eaah4680. https://doi.org/10.1126/scitranslmed.aah4680

Nguyen, T. T., Hathaway, H., Kosciolek, T., Knight, R., & Jeste, D. V. (2021). Gut microbiome in serious mental illnesses: A systematic review and critical evaluation. Schizophrenia Research, 234, 24-40. https://doi.org/10.1016/j.schres.2019.08.026

Oh, J., Byrd, A. L., Park, M., Kong, H. H., & Segre, J. A. (2016). Temporal stability of the human skin microbiome. Cell, 165(4), 854-866. https://doi.org/10.1016/j.cell.2016.04.008

O'Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2025). The gut microbiota-immune-brain axis: Therapeutic implications. Cell Reports Medicine, 6(3), 101982. https://doi.org/10.1016/j.xcrm.2025.101982

Palleja, A., Mikkelsen, K. H., Forslund, S. K., Kashani, A., Allin, K. H., Nielsen, T., Hansen, T. H., Liang, S., Feng, Q., Zhang, C., Pyl, P. T., Coelho, L. P., Yang, H., Wang, J., Typas, A., Nielsen, M. F., Nielsen, H. B., Bork, P., Wang, J., . . . Pedersen, O. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3(11), 1255-1265. https://doi.org/10.1038/s41564-018-0257-9

Park, J., Yang, S., Sohn, J., Lee, J., Lee, S., Ku, Y., & Kim, H. C. (2019). Cuffless and continuous blood pressure monitoring using a single chest-worn device. IEEE Access, 7, 135231-135246. https://doi.org/10.1109/access.2019.2942184

Pedersen, H. K., Gudmundsdottir, V., Nielsen, H. B., Hyotylainen, T., Nielsen, T., Jensen, B. A. H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., Le Chatelier, E., Levenez, F., Doré, J., Mattila, I., Plichta, D. R., Pöhö, P., Hellgren, L. I., Arumugam, M., Sunagawa, S., . . . Pedersen, O. (2016). Human gut microbes impact host serum metabolome and insulin sensitivity. Nature, 535(7612), 376-381. https://doi.org/10.1038/nature18646

Pluznick, J. L., Protzko, R. J., Gevorgyan, H., Peterlin, Z., Sipos, A., Han, J., Brunet, I., Wan, L. X., Rey, F., Wang, T., Firestein, S. J., Yanagisawa, M., Gordon, J. I., Eichmann, A., Peti-Peterdi, J., & Caplan, M. J. (2013). Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proceedings of the National Academy of Sciences, 110(11), 4410-4415. https://doi.org/10.1073/pnas.1215927110

Price, T. K., Wolff, B., Halverson, T., Limeira, R., Brubaker, L., Dong, Q., Mueller, E. R., & Wolfe, A. J. (2020). Temporal dynamics of the adult female lower urinary tract microbiota. mBio, 11(2), e00475-20. https://doi.org/10.1128/mBio.00475-20

Ramadan, Y. N., Alqifari, S. F., Alshehri, K., Alhowiti, A., Mirghani, H., Alrasheed, T., & Hetta, H. F. (2025). Microbiome gut-brain-axis: Impact on brain development and mental health. Molecular Neurobiology, 62(8), 10813-10833. https://doi.org/10.1007/s12035-025-04846-0

Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S. K., McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O., Brotman, R. M., Davis, C. C., Ault, K., Peralta, L., & Forney, L. J. (2011). Vaginal microbiome of reproductive-age women. Proceedings of the National Academy of Sciences, 108(Suppl. 1), 4680-4687. https://doi.org/10.1073/pnas.1002611107

Salter, S. J., Cox, M. J., Turek, E. M., Calus, S. T., Cookson, W. O., Moffatt, M. F., Turner, P., Parkhill, J., Loman, N. J., & Walker, A. W. (2014). Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biology, 12, 87. https://doi.org/10.1186/s12915-014-0087-z

Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013). Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism, 17(2), 225-235. https://doi.org/10.1016/j.cmet.2013.01.003

Scheitz, J. F., Sposato, L. A., Schulz-Menger, J., Nolte, C. H., Backs, J., & Endres, M. (2022). Stroke-heart syndrome: Recent advances and challenges. Journal of the American Heart Association, 11, e026528. https://doi.org/10.1161/jaha.122.026528

Segal, L. N., Clemente, J. C., Tsay, J.-C. J., Koralov, S. B., Keller, B. C., Wu, B. G., Li, Y., Shen, N., Ghedin, E., Morris, A., Diaz, P., Huang, L., Wikoff, W. R., Ubeda, C., Artacho, A., Rom, W. N., Sterman, D. H., Collman, R. G., Blaser, M. J., & Weiden, M. D. (2016). Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nature Microbiology, 1, 16031. https://doi.org/10.1038/nmicrobiol.2016.31

Sterling, P., & Eyer, J. (1988). Allostasis: A new paradigm to explain arousal pathology. In S. Fisher & J. Reason (Eds.), Handbook of life stress, cognition and health (pp. 629-649). John Wiley & Sons.

Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., Kubo, C., & Koga, Y. (2004). Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. The Journal of Physiology, 558(1), 263-275. https://doi.org/10.1113/jphysiol.2004.063388

Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., Federici, S., Horn, M., Cohen, Y., Moor, A. E., Zeevi, D., Korem, T., Kotler, E., Harmelin, A., Itzkovitz, S., Maharshak, N., . . . Elinav, E. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 174(6), 1406-1423.e16. https://doi.org/10.1016/j.cell.2018.08.047

Tang, W. H. W., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., Wu, Y., & Hazen, S. L. (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. The New England Journal of Medicine, 368(17), 1575-1584. https://doi.org/10.1056/NEJMoa1109400

Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61(3), 201-216. https://doi.org/10.1016/s0165-0327(00)00338-4

Thayer, J. F., & Lane, R. D. (2009). Claude Bernard and the heart-brain connection: Further elaboration of a model of neurovisceral integration. Neuroscience and Biobehavioral Reviews, 33(2), 81-88. https://doi.org/10.1016/j.neubiorev.2008.08.004

Thayer, J. F., Åhs, F., Fredrikson, M., Sollers, J. J., III, & Wager, T. D. (2012). A meta-analysis of heart rate variability and neuroimaging studies. Neuroscience and Biobehavioral Reviews, 36(2), 747-756. https://doi.org/10.1016/j.neubiorev.2011.11.009

Thayer, J. F., Hansen, A. L., Saus-Rose, E., & Johnsen, B. H. (2006). Beyond heart rate variability: Vagal regulation of allostatic systems. Annals of the New York Academy of Sciences, 1088(1), 361-372. https://doi.org/10.1196/annals.1366.014

The Human Microbiome Project Consortium. (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207-214. https://doi.org/10.1038/nature11234

The Integrative HMP Research Network Consortium. (2019). The Integrative Human Microbiome Project. Nature, 569(7758), 641-648. https://doi.org/10.1038/s41586-019-1238-8

Thomas-White, K., Forster, S. C., Kumar, N., Van Kuiken, M., Putonti, C., Stares, M. D., Hilt, E. E., Price, T. K., Wolfe, A. J., & Lawley, T. D. (2018). Culturing of female bladder bacteria reveals an interconnected urogenital microbiota. Nature Communications, 9, 1557. https://doi.org/10.1038/s41467-018-03968-5

Tonetti, M. S., D'Aiuto, F., Nibali, L., Donald, A., Storry, C., Parkar, M., Suvan, J., Hingorani, A. D., Vallance, P., & Deanfield, J. (2007). Treatment of periodontitis and endothelial function. The New England Journal of Medicine, 356(9), 911-920. https://doi.org/10.1056/NEJMoa063186

Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., & Marsland, B. J. (2014). Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nature Medicine, 20(2), 159-166. https://doi.org/10.1038/nm.3444

U.S. Food and Drug Administration. (2022). REBYOTA. https://www.fda.gov/vaccines-blood-biologics/vaccines/rebyota

U.S. Food and Drug Administration. (2023). FDA approves first orally administered fecal microbiota product for the prevention of recurrence of Clostridioides difficile infection. https://www.fda.gov/news-events/press-announcements/fda-approves-first-orally-administered-fecal-microbiota-product-prevention-recurrence-clostridioides

Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., Claes, S., Van Oudenhove, L., Zhernakova, A., Vieira-Silva, S., & Raes, J. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4(4), 623-632. https://doi.org/10.1038/s41564-018-0337-x

Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., Wu, Y., Schauer, P., Smith, J. D., Allayee, H., Tang, W. H. W., DiDonato, J. A., Lusis, A. J., & Hazen, S. L. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 472(7341), 57-63. https://doi.org/10.1038/nature09922

Wastyk, H. C., Fragiadakis, G. K., Perelman, D., Dahan, D., Merrill, B. D., Yu, F. B., Topf, M., Gonzalez, C. G., Van Treuren, W., Han, S., Robinson, J. L., Elias, J. E., Sonnenburg, E. D., Gardner, C. D., & Sonnenburg, J. L. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137-4153.e14. https://doi.org/10.1016/j.cell.2021.06.019

Wolfe, A. J., Toh, E., Shibata, N., Rong, R., Kenton, K., Fitzgerald, M., Mueller, E. R., Schreckenberger, P., Dong, Q., Nelson, D. E., & Brubaker, L. (2012). Evidence of uncultivated bacteria in the adult female bladder. Journal of Clinical Microbiology, 50(4), 1376-1383. https://doi.org/10.1128/JCM.05852-11

Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264-276. https://doi.org/10.1016/j.cell.2015.02.047

Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., Federici, S., Cohen, Y., Linevsky, R., Rothschild, D., Moor, A. E., Ben-Moshe, S., Harmelin, A., Itzkovitz, S., Maharshak, N., . . . Elinav, E. (2018). Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell, 174(6), 1388-1405.e21. https://doi.org/10.1016/j.cell.2018.08.041

About the Author

Fred Shaffer earned his PhD in Psychology from Oklahoma State University. He earned BCIA certifications in Biofeedback and HRV Biofeedback. Fred is an Allen Fellow and Professor of Psychology at Truman State University, where he has taught for 50 years. He is a Biological Psychologist who consults and lectures in heart rate variability biofeedback, Physiological Psychology, and Psychopharmacology. Fred helped to edit Evidence-Based Practice in Biofeedback and Neurofeedback (3rd and 4th eds.) and helps to maintain BCIA's certification programs. He is a recipient of AAPB's Distinguished Scientist Award and BFE's Lifetime Impact Award.

Support Our Friends

The Human Microbiome Network.pdf

Download PDF • 15.42MB